August 20, 2022 5 min read
What are CBD edibles? How effective are CBD edibles in the CBD market? What are some of the advantages of CBD edibles to an individual? Are they the future? This article explains how incredible CBD edibles are and if they are the future of CBD products.
In the cannabidiol (CBD) domain, CBD edibles are the most traded merchandise following their high demand. Since hemp legalization in 2018, numerous CBD products have emerged. For instance, CBD edibles are the most consumed and traded products within the cannabidiol domain. However, other CBD-related products have emerged. This article tries to explain whether CBD edibles are the future.
In 2018, the Farm Bill federally legalized the harvesting, manufacturing, and consumption of cannabidiol products. Since then, the innovation and use of cannabidiol have grown significantly. CBD brands began manufacturing different products, including CBD edibles, tinctures, and oils but recently, most people have prioritized CBD edibles following its incredible benefits. Consumers use these products since they are easily accessible, cheap, and convenient to deliver the daily cannabidiol dose. CBD edibles are the most traded merchandise in the CBD domain because of the high demand. However, other cannabidiol-related products are becoming popular. It makes certain individuals inquire whether CBD edibles carry the future. Here are related facts.
Cannabidiol (CBD) is an essential cannabinoid compound found in cannabis sativa (marijuana) and hemp plants, the cannabis variants. Notably, marijuana constitutes high tetrahydrocannabinol (THC), a molecule responsible for high effects in cannabis plants, while hemp contains high cannabidiol, a cannabinoid loaded with enormous health benefits. According to Piomelli et al. (2019), the 2018 Farm Bill federally-authorized cultivation, harvesting, manufacturing, and consumption of industrial hemp products. Thus, these products should have below 0.3 percent THC legal limit. However, marijuana-derived products, including edibles, remain illegal globally in most states. Many brands derive their cannabidiol from hemp plants implying that CBD edibles are safe. After hemp legalization, individuals throughout the United States can access cannabidiol in various products, especially edibles. Although you might hardly find cannabidiol being traded in certain regions, manufacturers can deliver these products to any client within the State. It brought a turnaround for most consumers who began taking cannabidiol edibles to acquire daily doses. Hemp legalization has propelled CBD edibles' popularity globally.
The CBD functioning involves two cannabinoid varieties, including Phytocannabinoids and endocannabinoids. Phytocannabinoids are derived from plants, while mammals produce endocannabinoids. The Phytocannabinoids are found in marijuana and hemp plants and various cannabis products. Specifically, the endocannabinoid system (ECS) in the human body controls metabolism, sleep, reproduction, pain, mood, appetite, and homeostasis (a state of body balance). When consumers take Phytocannabinoids through marijuana or hemp, it communicates with ECS, thus triggering its functioning and health. Anand et al. (2009) demonstrated that the human endocannabinoid system has CB2 and CB1 receptors. CB2 is found in the peripheral nervous system and immune cells, while CB1 is present in the human central nervous system. When people consume CBD edibles, the Phytocannabinoids interact with CB1 and CB2 receptors to generate numerous positive impacts on several body parts. The consumption of these products increases cannabinoids in the body, thus supporting the endocannabinoid system to function properly. Hazekamp (2018) stated that people prefer CBD edibles because they generate many health benefits after the cannabidiol compound interacts with the endocannabinoid system.
According to Suraev et al. (2017), cannabidiol-related pharmaceutical medications are approved to diagnose certain strains of epilepsy. Several people can benefit from cannabidiol edibles regardless of their medical condition. Also, these products are essential supplements for individuals with first-aid and milder-related ailments. Consumers consider ibuprofen or other anti-inflammatory medications when having joint pain, headache, and minor injury. Aziz et al. (2020) explained that cannabidiol functions similarly to pharmaceutical drugs without extreme side effects such as gastrointestinal bleeding and stomach ulcers.
Cannabidiol might come with certain side effects when consumed in huge amounts. Shover et al. (2019) showed that overdosing on cannabidiol might promote the effects of pharmaceutical drugs. It implies that customers should reduce their doses. Nevertheless, cannabidiol is well-tolerated, and moderate cannabinoids generate few side effects.
Consumers across nations can access CBD edibles online. Although the specific CBD regulations are ambiguous, most manufacturers trade cannabidiol online and deliver it throughout the United States, and also they are available in certain European countries. The cannabidiol edibles traded online are derived from hemp since cannabis sativa, and hemp come from a similar plant. However, cannabis sativa contains high THC that intoxicates consumers, and hemp is grown for seed and fiber, although the term describes low-THC or high-CBD cannabis cultivars. The United States Federal law legalized exclusively hemp containing below 0.3 percent THC.
Although some people prefer manufacturing enriched cooking oils or cannabidiol butter, CBD edibles are easy to prepare. Various cannabidiol extractions are integrated into baked or cooked goods for an extra antioxidant boost. Cannabidiol crystals made using isolated and purified cannabidiol are now accessible online and at cannabis-access locations. However, individuals should realize that isolated cannabidiol has lower effectiveness than entire-plant cannabis. Medium Chain Triglycerides (MCT) oil tinctures enriched with cannabidiol are minimal in the marketplace. These products can be easily dosed, thus providing the consumer with higher control over the CBD amount available per dose.
Some CBD formulations are impractical or cumbersome. Pocket vaporizers are huge and might limit users to get daily CBD doses. Edibles have small sizes, and consumers can carry them in pockets or purses. It makes it convenient to take CBD doses.
People unfamiliar with cannabidiol edibles are disadvantaged. These products offer an incredible method to acquire the required cannabidiol dosage. Also, CBD oils and tinctures have various benefits, although minimal. But CBD edibles are legal in most states throughout the United States. However, the 2018 Farm Bill legalized only CBD products containing below 0.3 percent THC. Most legitimate CBD brands source their cannabidiol from hemp, which means that CBD edibles are accessed by many people in physical and online stores as the products have high demand across nations. Cannabidiol edibles have more benefits than other cannabis products, making them carry the future of the CBD industry.
Anand, Whiteside, Fowler, & Hohmann (2009). Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain research reviews, 60(1), 255-266.
Aziz, A., Waheed, T., Oladunjoye, O., Oladunjoye, A., Hanif, M., & Latif, F. (2020). Topical capsaicin for treating cannabinoid hyperemesis syndrome. Case Reports in Gastrointestinal Medicine, 2020.
Hazekamp, A. (2018). The trouble with CBD oil. Medical cannabis and cannabinoids, 1(1), 65-72.
Suraev, Todd, Bowen, Allsop, McGregor, Ireland, & Lintzeris (2017). An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy & Behavior, 70, 334-340.
Shover, Davis, Gordon, & Humphreys (2019). Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences, 116(26), 12624-12626.
Piomelli, Solomon, Abrams, Balla, Grant, Marcotte, & Yoder, (2019). Regulatory barriers to research on cannabis and cannabinoids: A proposed path forward. Cannabis and Cannabinoid Research, 4(1), 21-32.
Enter our weekly prize draw to win cool prizes from our store!